Evidence map›Paper›PMID 34195691›Full record

ReviewFaculty reviews2021

Novel and atypical pathways for serotonin signaling.

Joël Bockaert, Carine Bécamel, Séverine Chaumont-Dubel, Sylvie Claeysen, Franck Vandermoere, Philippe Marin

Open access · diamondAbstract readReview
In one paragraph

Review in Faculty reviews, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Novel, small molecules targeting the 5-HTbioRxiv : the preprint server for biology · 2025
    Article
  5. Biased signalingActa pharmaceutica Sinica. B · 2025
    Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Presynaptic 5-HTCells · 2022
    Article
  20. Metagenomic-Metabolomic Mining ofFrontiers in microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Joël BockaertThe Institute of Functional Genomics (IGF), University of Montpellier, CNRS, INSERM, Montpellier, France.
Carine BécamelThe Institute of Functional Genomics (IGF), University of Montpellier, CNRS, INSERM, Montpellier, France.
Séverine Chaumont-DubelThe Institute of Functional Genomics (IGF), University of Montpellier, CNRS, INSERM, Montpellier, France.
Sylvie ClaeysenThe Institute of Functional Genomics (IGF), University of Montpellier, CNRS, INSERM, Montpellier, France.
Franck VandermoereThe Institute of Functional Genomics (IGF), University of Montpellier, CNRS, INSERM, Montpellier, France.
Philippe MarinThe Institute of Functional Genomics (IGF), University of Montpellier, CNRS, INSERM, Montpellier, France.
Centre National de la Recherche Scientifique · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Serotonin (5-HT) appeared billions of years before 5-HT receptors and synapses. It is thus not surprising that 5-HT can control biological processes independently of its receptors. One example is serotonylation, which consists of covalent binding of 5-HT to the primary amine of glutamine. Over the past 20 years, serotonylation has been involved in the regulation of many signaling mechanisms. One of the most striking examples is the recent evidence that serotonylation of histone H3 constitutes an epigenetic mark. However, the pathophysiological role of histone H3 serotonylation remains to be discovered. All but one of the 5-HT receptors are G-protein-coupled receptors (GPCRs). The signaling pathways they control are finely tuned, and new, unexpected regulatory mechanisms are being uncovered continuously. Some 5-HT receptors (5-HT

Indexed as

GPCR interacting proteinheteromerizationreceptorSerotoninserotonylation

Identifiers

PMID34195691
PMCPMC8204760
OpenAlexW3171123621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.